GlaxoSmithKline PLC Total Voting Rights (7831X)
01 Mayo 2019 - 8:32AM
UK Regulatory
TIDMGSK
RNS Number : 7831X
GlaxoSmithKline PLC
01 May 2019
GlaxoSmithKline plc
Total Voting Rights and Capital
In conformity with the Financial Conduct Authority's Disclosure
Guidance and Transparency Rule 5.6.1R, GlaxoSmithKline plc (the
'Company') hereby notifies the market of the following:
The Company's issued share capital as at 30 April 2019 consisted
of 5,381,291,784 shares of 25 pence each ('Ordinary Shares'), of
which 393,505,950 Ordinary Shares were held in Treasury.
Therefore, the total number of voting rights in the Company is
4,987,785,834. This figure may be used by shareholders as the
denominator for the calculations by which they will determine if
they are required to notify their interest in, or a change to their
interest in, the Company under the Financial Conduct Authority's
Disclosure Guidance and Transparency Rules.
V A Whyte
Company Secretary
1 May 2019
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
END
TVRUGUUWAUPBGWG
(END) Dow Jones Newswires
May 01, 2019 09:32 ET (13:32 GMT)
Gsk (LSE:GSK)
Gráfica de Acción Histórica
De Mar 2024 a Abr 2024
Gsk (LSE:GSK)
Gráfica de Acción Histórica
De Abr 2023 a Abr 2024